It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
A promising line of research into treatment for tinnitus, Acceptance and Commitment Therapy (ACT), reduces the severity of tinnitus distress by approximately one-third. However, the ability to provide ACT therapy for tinnitus is currently compromised by COVID-19 restrictions. A method of circumventing COVID-19 restrictions is suggested by a novel Swedish online treatment study (Hesser et al., 2012), in which the use of ACT and CBT to treat tinnitus was provided over the Internet. The proposed clinical study investigates whether the Hesser online protocol can be replicated and adapted for use by a U.S. audience. Method: Participants are invited to a treatment website at www.zerotinnitus.com where they are assessed with standardized self-report measures (Acceptance and Action Questionnaire–II, Cognitive Fusion Questionnaire, Valued Living Questionnaire, Tinnitus Handicap Inventory and Tinnitus Acceptance Questionnaire) at pre- and post-treatment. Results: Data gathering is ongoing due to pandemic conditions. The dataset is provided to researchers without charge for analysis and for use in combination with other interventions being studied. Discussion: A translated and adapted web-based intervention using ACT for the treatment of tinnitus was provided for use by a U.S. audience but the study experienced a high drop out rate.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer